Blue Sea Capital Closes $800 Million Healthcare Fund

The West Palm Beach private equity firm's Fund IV exceeded its target and original hard cap within four months of launch.

Updated on Nov. 17, 2026 in Business

Blue Sea Capital Closes $800 Million Healthcare Fund

Blue Sea Capital, a healthcare-focused private equity firm based in West Palm Beach, Florida, closed Blue Sea Capital Fund IV and its executive fund with $800 million in aggregate commitments. The fund surpassed its $550 million target and its original $700 million hard cap.

Why it matters

The fund's size reflects strong investor demand for healthcare-focused private equity in the lower middle market, and it is the firm's first vehicle dedicated exclusively to healthcare. For West Palm Beach, home to the firm, the close adds to the local concentration of investment capital.

Fund IV's $800 million in commitments is roughly 29% larger than the predecessor fund's nearly $620 million, and the firm closed four exits in 2026 totaling about $1.5 billion in enterprise value. The announcement does not disclose how the commitments are divided among investors or the timeline for deploying the capital.

The players

Blue Sea Capital

A healthcare-focused private equity firm based in West Palm Beach, Florida, that invests in North American lower-middle-market companies.

The details

Blue Sea Capital secured commitments above its revised cap within four months of launching the fund in May. The firm targets North American lower-middle-market companies with $5 million to $30 million in EBITDA and completed exits of SignatureMD, WillowWood, One Physics and Spectrum Vision Partners while adding three platforms: Scout, CompletePet and Dynamic Access.

Timeline

  1. May 2026: Blue Sea launches Fund IV.

  2. Within four months of launch: Commitments exceed the revised fund cap.

  3. 2026: Four exits completed and three platforms added.

Market Landscape

Fund IV marks Blue Sea's shift from a diversified mandate to a healthcare-only vehicle, following the firm's predecessor fund that raised nearly $620 million. The larger close positions the firm to compete for healthcare deals in the lower middle market against other sector-focused private equity sponsors.

For healthcare businesses in the lower middle market with $5 million to $30 million in EBITDA, the fund signals active capital available for acquisition and growth. The announcement does not indicate any direct change to pricing or availability for consumers of healthcare services.

The takeaway

Strong fundraising for a sector-focused fund shows that investors continue to back healthcare businesses in the lower middle market. Companies in that size range should note that dedicated capital is available for growth-stage deals.

Further reading

Explore more healthcare industry news from across the business desk.

Source note: This article includes information reported by Hedgeco.